Germany
Japan
United Kingdom
China
Cardiac Troponin I (TNNI3) mouse monoclonal antibody, clone 84
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Antibodies
DownloadUSD 435.00
2 Weeks
Cardiac Troponin I (TNNI3) (+ skeletal) mouse monoclonal antibody, clone C5
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 435.00
2 Weeks
Cardiac Troponin I (TNNI3) (+ skeletal) mouse monoclonal antibody, clone M46
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Trpm7 mouse monoclonal antibody, clone N74/25
| Applications | IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 375.00
2 Weeks
USD 485.00
2 Weeks
alpha 1 Fetoprotein (AFP) mouse monoclonal antibody, clone AFP-Y2, Aff - Purified
| Applications | ELISA, IP, R, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 485.00
2 Weeks
alpha 1 Fetoprotein (AFP) mouse monoclonal antibody, clone AFP-Y1, Aff - Purified
| Applications | ELISA, IP, R, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
HSP70-1A (HSPA1A) mouse monoclonal antibody, clone SJ-70, Purified
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CLEC10A mouse monoclonal antibody, clone 121A5.01
| Applications | IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Reactivities
- Human
Applications
- IP
Clonalities
- Monoclonal
Filter by
Target Symbol
- LIPG (105)
- BRAF (70)
- MAPK1 (53)
- FCGR2A (47)
- CRYAB (45)
- NEUROG1 (45)
- NRBP1 (45)
- RALBP1 (45)
- LTA4H (40)
- L1CAM (37)
- RPA2 (36)
- GBE1 (35)
- TYRO3 (35)
- PIM2 (30)
- PLK1 (30)
- SLC2A5 (30)
- SSB (30)
- CHEK2 (26)
- DAPK2 (25)
- SERPINA1 (25)
- LDHA (22)
- FERMT2 (20)
- LEMD3 (20)
- MAP2K4 (20)
- MYC (18)
- GAD1 (15)
- HDAC10 (15)
- NEK6 (15)
- USP13 (15)
- AKT2 (10)
- SLC7A8 (10)
- TUBA8 (10)
- NEUROG3 (9)
- CCR5 (6)
- BAX (5)
- CD74 (5)
- GADD45G (5)
- PROM2 (5)
- SHC1 (5)
- SORD (5)
- ACTA1 (4)
- ADRB2 (4)
- AOC3 (4)
- CD22 (4)
- CD40 (4)
- EGFR (4)
- INSR (4)
- MAPT (4)
- MS4A4A (4)
- MSLN (4)
- MUC1 (4)
- VEGFA (4)
- APP (3)
- CYCS (3)
- EIF4E (3)
- HRAS (3)
- ITGB2 (3)
- LGR5 (3)
- NFKBIA (3)
- RELA (3)
- SCARB1 (3)
- SLAMF7 (3)
- STAT1 (3)
- TYRP1 (3)
- ABCB1 (2)
- AFP (2)
- AHSA1 (2)
- AKT1 (2)
- ATF2 (2)
- ATM (2)
- C5AR1 (2)
- CACNB2 (2)
- CASP3 (2)
- CD15 (2)
- CD16 (2)
- CD19 (2)
- CD1A (2)
- CD27 (2)
- CD34 (2)
- CD38 (2)
- CD4 (2)
- CD44 (2)
- CD53 (2)
- CD63 (2)
- CD8 (2)
- CD80 (2)
- CD81 (2)
- CDK4 (2)
- CDX2 (2)
- CNTNAP2 (2)
- CREB1 (2)
- CSF2RB (2)
- CYCLIN H (2)
- ENO1 (2)
- EPCAM (2)
- ERBB2 (2)
- FCAR (2)
- FUBP1 (2)
- GSDME (2)
- H2AX (2)
Antibody Hosts
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (25)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (10)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (826)
- Protein Kinase (360)
- ES Cell Differentiation/IPS (175)
- Transmembrane (154)
- Secreted Protein (132)
- Transcription Factors (115)
- Stem cell - Pluripotency (101)
- Protease (55)
- Adult stem cells (3)
- GPCR (3)
- Embryonic stem cells (2)
- Ion Channels: Other (2)
- Nuclear Hormone Receptor (1)
Pathways
- Metabolic pathways (224)
- Pathways in cancer (209)
- Pancreatic cancer (178)
- Progesterone-mediated oocyte maturation (163)
- Acute myeloid leukemia (161)
- MAPK signaling pathway (158)
- ErbB signaling pathway (156)
- Bladder cancer (146)
- Chemokine signaling pathway (138)
- Chronic myeloid leukemia (138)
- Neurotrophin signaling pathway (138)
- Glioma (137)
- Insulin signaling pathway (137)
- Focal adhesion (136)
- Prostate cancer (135)
- Colorectal cancer (133)
- Melanoma (132)
- Non-small cell lung cancer (132)
- Renal cell carcinoma (132)
- mTOR signaling pathway (132)
- Endometrial cancer (131)
- Natural killer cell mediated cytotoxicity (126)
- Regulation of actin cytoskeleton (125)
- Long-term depression (120)
- Long-term potentiation (120)
- Thyroid cancer (120)
- Vascular smooth muscle contraction (120)
- Fc gamma R-mediated phagocytosis (106)
- Glycerolipid metabolism (105)
- Axon guidance (85)
- Toll-like receptor signaling pathway (83)
- Fc epsilon RI signaling pathway (81)
- Oocyte meiosis (80)
- Systemic lupus erythematosus (75)
- GnRH signaling pathway (70)
- Cell cycle (66)
- T cell receptor signaling pathway (63)
- B cell receptor signaling pathway (62)
- VEGF signaling pathway (61)
- Gap junction (60)
- Adherens junction (55)
- NOD-like receptor signaling pathway (53)
- Prion diseases (53)
- Alzheimer's disease (52)
- Type II diabetes mellitus (51)
- Dorso-ventral axis formation (50)
- Melanogenesis (50)
- TGF-beta signaling pathway (50)
- Arachidonic acid metabolism (40)
- Nucleotide excision repair (40)
- DNA replication (38)
- Cell adhesion molecules (CAMs) (37)
- Homologous recombination (37)
- Mismatch repair (37)
- Starch and sucrose metabolism (35)
- p53 signaling pathway (32)
- Complement and coagulation cascades (25)
- Glycolysis / Gluconeogenesis (22)
- Pyruvate metabolism (22)
- Epithelial cell signaling in Helicobacter pylori infection (21)
- Cysteine and methionine metabolism (20)
- Propanoate metabolism (20)
- Tight junction (16)
- Type I diabetes mellitus (16)
- Alanine (15)
- Butanoate metabolism (15)
- Pathogenic Escherichia coli infection (15)
- Taurine and hypotaurine metabolism (15)
- aspartate and glutamate metabolism (15)
- beta-Alanine metabolism (15)
- Apoptosis (14)
- Small cell lung cancer (14)
- Adipocytokine signaling pathway (13)
- Jak-STAT signaling pathway (12)
- Maturity onset diabetes of the young (9)
- Hypertrophic cardiomyopathy (HCM) (7)
- Dilated cardiomyopathy (6)
- Huntington's disease (6)
- Viral myocarditis (6)
- Antigen processing and presentation (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Fructose and mannose metabolism (5)
- Leukocyte transendothelial migration (5)
- Non-homologous end-joining (5)
- Vibrio cholerae infection (5)
- Amyotrophic lateral sclerosis (ALS) (2)
- Cardiac muscle contraction (2)
- Endocytosis (2)
- Oxidative phosphorylation (2)
- Parkinson's disease (2)
- RIG-I-like receptor signaling pathway (2)
- Spliceosome (2)
- Basal transcription factors (1)
- Base excision repair (1)
- Citrate cycle (TCA cycle) (1)
- Cytosolic DNA-sensing pathway (1)
- Porphyrin and chlorophyll metabolism (1)
- Primary immunodeficiency (1)
- Purine metabolism (1)
- RNA degradation (1)